Target intelligence / Profile preview

Thiol:disulfide interchange protein DsbA (DsbA)

Target
DsbA
Molecular classification
Enzyme, Oxidoreductase, Thioredoxin-like protein
01

Overview

Thiol:disulfide interchange protein DsbA is a critical periplasmic enzyme found in Gram-negative bacteria, where it serves as the primary catalyst for the formation of disulfide bonds in proteins [2, 11]. As a member of the thioredoxin-like superfamily, DsbA possesses a highly oxidizing redox potential, allowing it to efficiently transfer disulfide bonds to nascent polypeptides as they enter the periplasm [7, 12]. This oxidative folding is essential for the structural integrity and functional maturation of numerous virulence factors, including toxins, adhesins, and secretion system components [3, 10]. Consequently, DsbA is a major determinant of bacterial pathogenesis across a wide range of species, such as Escherichia coli, Pseudomonas aeruginosa, and Vibrio cholerae [9, 15]. Because DsbA is required for virulence but typically not for bacterial viability, it is considered an attractive target for the development of anti-virulence drugs [3, 4]. Such agents aim to disarm the pathogen without exerting the intense selective pressure that drives the emergence of antibiotic resistance [6, 13]. Current drug discovery efforts focus on small molecules, including covalent inhibitors and peptidomimetics, that block the DsbA active site or its substrate-binding groove [4, 9].

Other names
DsbAdsfppfAPeriplasmic protein disulfide isomeraseDithiol oxidase
02

Mechanism of action

Inhibition of DsbA-mediated oxidative folding of bacterial virulence factors, thereby attenuating pathogenesis without affecting bacterial viability.

03

Biological functions

Disulfide bond formationProtein foldingVirulence factor assemblyThiol-disulfide exchangeRedox homeostasisOther
04

Disease associations

Infection
05

Safety considerations

Selectivity over human thioredoxin and other host redox enzymesStructural diversity of DsbA homologs across different bacterial speciesPotential for compensatory pathways (e.g., DsbC) to bypass inhibition
06

Interacting drugs

Experimental inhibitors (e.g., dimedone derivatives, peptidomimetics like PWATCDS analogues)
07

Biomarkers

Bacterial virulence factor expression levelsBacterial load in infection models

Beyond the preview

Go deeper on Thiol:disulfide interchange protein DsbA (DsbA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thiol:disulfide interchange protein DsbA (DsbA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call